Table 2.
Perioperative features of patients.
| Features | Standard AP (group A) n = 46 |
Prolonged AP (group B) n = 46 |
Р value | ||
|---|---|---|---|---|---|
| Laparoscopic access, abs. (%) | 44 (95.7) | 43 (93.5) | 1.0 | ||
| Laparotomy access, abs. (%) | 2 (4.3) | 3 (6.5) | |||
| Blood loss, Me (Q1-Q3) ml | 300.0 (150.0–400.0) |
325.0 (212.5–500.0) |
0.133 | ||
| Duration of operation, Me (Q1-Q3), min | 267.5 (232.5–342.5) | 297.5 (250.0–358.8) | 0.246 | ||
| Drainage of the abdominal cavity, abs. (%) | 11 (23.9) | 13 (28.3) | 0.635 | ||
| Urinary diversion (as treated) | |||||
| Heterotopic, abs. (%) | 33 (71.7) | 35 (76.1) | 0.822 | ||
| Orthotopic, abs. (%) | 6 (13.0) | 6 (13.0) | |||
| Other types*, abs. (%) | 7 (15.2) | 5 (10.9) | |||
| Pathological characteristics | |||||
| Histological variant -pure type, abs. (%) -variant histology, abs. (%) |
42 (91.3) 4 (8.7) |
39 (84.8) 7 (15.2) |
0.522 | ||
| Positive surgical margin**, abs. (%) | 4 (8.7) | 2 (4.3) | 0.677 | ||
| ypT0, abs. (%) | 7 (15.2) | 13 (28.3) | 0.048 | ||
| pT1, abs. (%) | 14 (30.4) | 5 (10.9) | |||
| pT2a, pT2b, abs. (%) | 4 (8.7) | 11 (23.9) | |||
| pT3a, abs. (%) | 5 (10.9) | 5 (10.9) | |||
| pT3b, abs. (%) | 8 (17.4) | 6 (13.0) | |||
| pT4a, abs. (%) | 5 (10.9) | 6 (13.0) | |||
| pT4b, abs. (%) | 3 (6.5) | 0 (0.0) | |||
| pN0, abs. (%) | 35 (76.1) | 36 (78.3) | 0.903 | ||
| pN1–3, abs. (%) | 11 (23.9) | 10 (21.7) | |||
| Length of hospitalization, Me (Q1-Q3), days | 19.0 (13.0–22.0) | 17.0 (14.0–21.8) | 0.398 | ||
| 30-days mortality, аbs. (%) | 2 (4.3) | 1 (2.2) | 1.0 | ||
| Removal of ureteral stents, Me (Q1-Q3), days | 9.0 (7.0–11.0) | 10.0 (8.0–12.0) | 0.162 | ||
| Removal of the urethral catheter*, М±SD (95% CI), days | 21.8 ± 12,7 (6.1–37.6) |
20.2 ± 8.0 (10.4–30.0) |
0.817 | ||
| Re-administration antibiotics rate, abs. (%) | 22 (47.8) | 8 (17.4) | 0.002 | ||
| Types of organisms in samples | |||||
| Sample 1 (positive), abs. (%) | 16 (34.8) | 18 (39.1) | 0.666 | ||
| Sample 2 (positive), abs. (%) | 22 (47.8) | 14 (30.4) | 0.087 | ||
| Sample 3 (positive), abs. (%) | 11 (23.9) | 4 (8.7) | 0.088 | ||
| Carbapenemase producers’ strain in Sample 1, abs. (%) | 1 (2.2) | 1 (2.2) | 0.111 | ||
| Carbapenemase producers’ strain in Sample 2 and Sample 3, abs. (%) | 6 (13.0) | 1 (2.2) | |||
| Type of Carbapenemase, abs. (%) |
OXA 48, NDM | 7 (15.2) | 1 (2.2) | 0.055 | |
| VIM, NDM | 0 (0.0) | 1 (2.2) | |||
*Other – operation was not performed (1 case) or the operation was completed by removing the ureterocutaneostomy or applying a nephrostomy drainage; positive surgical margin of the ureters, urethra, or invasion into the pelvic wall; The data was present for all variables in all patients.